ORGO
Organogenesis Holdings Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.42
+4.41%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$1.35
From 52W high−78.29%
Volume910861.00
Market cap$182.72M
P/E (TTM)—
P/S (TTM)0.4x
Div yield—
Key dataSep 18, 2026
Open
$1.35
From 52W high
−78.29%
Volume
910861.00
Market cap
$182.72M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−72.6x
P/E (TTM)
—
RSI (14)
26.7
MomentumView details →
1D Return
+4.41%
YTD Return
−73.46%
SummaryUpdated Jun 1, 2026
Organogenesis Holdings Inc. (NASDAQ:ORGO) is a regenerative medicine company founded in 1985 and headquartered in Canton, Massachusetts. The company develops, manufactures, and commercializes advanced biological solutions primarily for wound care and surgical applications. Since going public in 2017, Organogenesis has established itself as a leading player in the regenerative medicine space, focusing on products that harness the body's natural healing processes to treat complex medical conditions.
Similar companies
Latest newsMore news →